Welch Allyn, Sensitron partner to combine wireless monitoring technology:
This article was originally published in Clinica
Executive Summary
Welch Allyn has partnered with wireless data management specialists Sensitron (San Mateo, California) and its exclusive distributors in Europe, UK and the Middle East, in a bid to enhance the handling of medical data. The alliance aims to ensure that data from Welch Allyn's key vital signs monitors and spot-checking devices is recorded, either wirelessly or otherwise, with the Sensitron's careTrends digital clipboard technology and automatically sent to an electronic medical record, thus helping to reduce transcription errors, and minimise the time lag between the capture and posting of data. According to Sensitron, nurses can save between 35-40 minutes per shift with the use of the careTrends technology.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.